Study Examines Differences Between Planned and Delivered Radiation Doses in Proton Therapy for Throat Cancer
Researchers have published a preprint analyzing differences between planned, delivered, and variable relative biological effectiveness (RBE) doses in a cohort of base-of-tongue cancer patients treated with intensity-modulated proton therapy (IMPT). Head and neck patients are particularly vulnerable to anatomical changes during long treatment courses, making accurate dose delivery assessment critical, while the standard clinical RBE constant of 1.1 is known to underestimate true biological effect especially at beam endpoints. The study addresses a gap in clinical tools for evaluating planned versus delivered dose discrepancies, which has direct implications for treatment safety and efficacy in proton therapy.
A preprint submitted to arXiv by Wang et al. investigates the differences between planned doses, actually delivered doses, and variable RBE-weighted doses in patients with base-of-tongue cancer receiving intensity-modulated proton therapy. The authors note that, to their knowledge, no clinical tools are currently installed to routinely evaluate planned-versus-delivered dose differences, representing a significant gap in proton therapy quality assurance. Head and neck cancer patients are considered especially susceptible to anatomical changes over the course of treatment due to long treatment durations and difficulties with nutrition, making dose discrepancies particularly consequential for this population. The study also addresses the variable RBE problem: while a constant RBE of 1.1 is universally applied in clinical proton therapy, the true biological effectiveness of protons is known to exceed this value, especially near the distal end of the beam range where dose gradients are steep. The paper includes six figures and tables analyzing how these differences manifest and what their influence is on plan evaluation. The work highlights both a dosimetric and radiobiological uncertainty that may affect clinical decision-making for proton therapy patients.
What's missing
As a preprint, this work has not yet undergone formal peer review. Key study limitations not detailed in the abstract include the cohort size, the specific magnitude of dose differences observed, the clinical significance thresholds used, and whether any dosimetric deviations were associated with patient outcomes. The methodology for computing variable RBE (e.g., which biological model was used) is not described in the abstract. It is also unclear whether the findings are generalizable beyond base-of-tongue cancer to other head and neck subsites.
What different sources said
- arXiv physicsCenter
Planned, delivered and variable RBE dose difference analysis for a patient cohort with base-of-tongue cancer treated with IMPT
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.